CT扫描与癌症风险的流行病学研究:科学现状
本文综述了17项基于医疗记录链接的流行病学研究,评估CT扫描辐射暴露与癌症风险的关系。儿童期暴露的荟萃分析显示,白血病/骨髓增生异常综合征的汇总ERR/100 mGy为1.78(95%CI: 0.01-3.53),脑肿瘤为0.80(95%CI: 0.48-1.12)。结论认为CT扫描可能致癌的证据日益增多,但个体绝对风险可能较小。
要点
- 儿童CT暴露与白血病、脑肿瘤风险呈正相关,但个体绝对风险可能较小。
- 研究间方法学差异大(暴露指标、偏倚控制等),直接比较结果需谨慎。
- 脑肿瘤风险估计可能因反向因果而高估,白血病研究混杂可能性低。
核心结论
- 流行病学证据日益增多,提示CT扫描可致癌,但个体绝对风险可能较小。
- 正在进行的多中心队列和未来汇总分析将提供更精确的风险量化。
研究设计与样本
- 综述了17项基于医疗记录链接的流行病学研究,其中13项已发表风险估计,4项正在进行。
- 研究间方法学差异大,包括暴露时期(儿童期或成年期)、结局(辐射敏感肿瘤或所有癌症)、暴露指标(器官剂量、有效剂量或CT次数)及偏倚控制(潜伏期、排除期、适应证混杂)。
诊断标准与关键数值
- 8项白血病风险研究(基于红骨髓剂量、有效剂量或CT次数),7项报告正剂量反应,其中4项有统计学意义(p<0.05)。
- 7项脑肿瘤研究,6项报告正剂量反应,其中5项有统计学意义。
- 平均红骨髓剂量范围为6至12 mGy,平均脑剂量范围为18至43 mGy。
- 儿童期暴露荟萃分析:白血病/骨髓增生异常综合征汇总ERR/100 mGy为1.78(95%CI: 0.01-3.53,n=5项研究);脑肿瘤为0.80(95%CI: 0.48-1.12,n=4项研究),异质性p>0.4。
- 白血病研究的癌症易感条件混杂可能性不大;脑肿瘤汇总风险估计可能因反向因果而高估。
临床应用与阅片要点
- 了解CT辐射致癌的流行病学证据,有助于在临床实践中合理评估检查获益与风险。
- 儿童CT检查应特别关注辐射剂量优化,因儿童期暴露与白血病、脑肿瘤风险相关。
局限性
- 研究间方法学差异大,使结果比较困难。
- 脑肿瘤风险估计可能因反向因果而高估。
- 个体绝对风险可能较小,精确量化需等待正在进行的大型多中心队列和汇总分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
20 years ago, 3 manuscripts describing doses and potential cancer risks from CT scans in children raised awareness of a growing public health problem. We reviewed the epidemiological studies that were initiated in response to these concerns that assessed cancer risks from CT scans using medical record linkage. We evaluated the study methodology and findings and provide recommendations for optimal study design for new efforts. We identified 17 eligible studies; 13 with published risk estimates, and 4 in progress. There was wide variability in the study methodology, however, which made comparison of findings challenging. Key differences included whether the study focused on childhood or adulthood exposure, radiosensitive outcomes (e.g. leukemia, brain tumors) or all cancers, the exposure metrics (e.g. organ doses, effective dose or number of CTs) and control for biases (e.g. latency and exclusion periods and confounding by indication). We were able to compare results for the subset of studies that evaluated leukemia or brain tumors. There were eight studies of leukemia risk in relation to red bone marrow (RBM) dose, effective dose or number of CTs; seven reported a positive dose-response, which was statistically significant (p < 0.05) in four studies. Six of the seven studies of brain tumors also found a positive dose-response and in five, this was statistically significant. Mean RBM dose ranged from 6 to 12 mGy and mean brain dose from 18 to 43 mGy. In a meta-analysis of the studies of childhood exposure the summary ERR/100 mGy was 1.78 (95%CI: 0.01-3.53) for leukemia/myelodisplastic syndrome (n = 5 studies) and 0.80 (95%CI: 0.48-1.12) for brain tumors (n = 4 studies) (p-heterogeneity >0.4). Confounding by cancer pre-disposing conditions was unlikely in these five studies of leukemia. The summary risk estimate for brain tumors could be over estimated, however, due to reverse causation. In conclusion, there is growing evidence from epidemiological data that CT scans can cause cancer. The absolute risks to individual patients are, however, likely to be small. Ongoing large multicenter cohorts and future pooling efforts will provide more precise risk quantification.
引用
- Berrington de Gonzalez A, Pasqual E, Veiga L, et al. Epidemiological studies of CT scans and cancer risk: the state of the science. Br J Radiol. 2021. PMID: 34545766. doi:10.1259/bjr.20210471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。